Premium
Mapping technological capabilities into product markets and competitive advantage: the case of cholesterol drugs
Author(s) -
Afuah Allan
Publication year - 2002
Publication title -
strategic management journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 11.035
H-Index - 286
eISSN - 1097-0266
pISSN - 0143-2095
DOI - 10.1002/smj.221
Subject(s) - competitive advantage , software deployment , industrial organization , business , product (mathematics) , value (mathematics) , empirical evidence , customer value , marketing , computer science , economics , microeconomics , profit (economics) , philosophy , geometry , mathematics , epistemology , machine learning , operating system
While a lot of attention has been paid to those characteristics of capabilities that give firms a competitive advantage, a lot less attention has been given to supporting empirical evidence and to the deployment of these capabilities. This paper presents a model for mapping firm capabilities into customer value and competitive advantage in different markets. With empirical evidence from cholesterol drugs, I illustrate how the model can be used to estimate customer value and competitive advantage from technological capabilities. Copyright © 2002 John Wiley & Sons, Ltd.